FGF23 and hypophosphatemia: The molecular pathways connecting FGF23 to abnormal bone development have since been further elucidated and include hypophosphatemia-mediated pathways and autocrine/paracrine pathways, which are respectively illustrated in parts A and B of Fig. 5 [84, 85].